PATENT CLAIM ANALYSIS

Application Number: 16084238
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["514", "691000"]

Abstract:
Disclosed is a use of a nootkatone in the preparation of medicines for preventing and/or treating depression. The nootkatone has a significant efficacy which is better than that of the existing antidepressant drug Prozac; and it has a wide range of sources and offers more choices for preventing and treating depression.

Claim (Index 2):
The method according to  claim 1 , wherein nootkatone is an oral preparation, an injection preparation or an external preparation.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.45946
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12304114', '13502880', '14423084', '11141497', '13866145']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.692575555038489
- 35 USC 102 Novelty (BERT): 0.5056398301825047
- Combined Prediction Score: 0.6738819825528906
- Mean Citation Score: 133.12471200000002
- Max Citation Score: 143.1085
- Similarity Product: 82.77572436133026

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test